Phantom Limb Pain (Investigational)
Highly investigational adjunct for chronic phantom limb pain; no clinical study identified; mirror therapy and gabapentinoids remain primary.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for phantom limb pain. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.
- What evidence exists?
- Tier C (investigational). No controlled trials or case reports of leech therapy for phantom limb pain were identified in PubMed or Europe PMC. Evidence-based therapies include mirror therapy and graded motor imagery (the strongest RCT support, low-risk and inexpensive), pharmacotherapy (gabapentin, pregabalin, amitriptyline, duloxetine), opioids in selected refractory patients, transcutaneous electrical nerve stimulation (TENS), and targeted muscle reinnervation surgery or peripheral nerve stimulation for refractory cases. Most amputees report some phantom sensation; pain that interferes with function or sleep is the treatment target.
- Main risks
- Bleeding from each bite site for 6 to 24 hours after detachment
- Bruising over the residual limb for 5 to 10 days
- Risk of triggering neuroma pain or worsening phantom sensation by stimulating the stump
- Local skin or, rarely, Aeromonas hydrophila infection
- Risk of disrupting prosthetic socket fit and rehabilitation progress
- Allergic reaction to leech saliva (uncommon)
- Delay of evidence-based mirror therapy, graded motor imagery, and pharmacotherapy
- Who should not consider this
- Patients with stump skin breakdown, ulceration, or unhealed surgical wounds
- Patients with active neuroma or stump infection
- Patients in active prosthetic fitting or rehabilitation phase (skin must remain pristine)
- Patients who have not tried mirror therapy, graded motor imagery, and adequate pharmacotherapy
- Patients on anticoagulants, with hemophilia, or with anemia
- Patients with peripheral vascular disease that contributed to the amputation
- Diabetic amputees with high infection risk
- What to ask your clinician
- Have I tried mirror therapy and graded motor imagery - the highest-evidence non-pharmacologic treatments?
- Have I tried gabapentin, pregabalin, amitriptyline, or duloxetine at adequate doses and duration?
- Have I tried TENS, and have I been evaluated for peripheral nerve stimulation or targeted muscle reinnervation?
- Is the pain truly phantom limb pain, or could it be residual limb pain, neuroma pain, or back pain referred to the limb?
- How will leech therapy interact with my prosthetic socket fit and rehabilitation schedule?
- Where exactly will leeches be placed - confirm placement avoids the stump scar and any neuroma site?
- What is the Aeromonas-prevention protocol?
- When to seek urgent care
- Sudden severe stump pain, redness, swelling, or warmth (possible infection)
- Drainage, pus, or open wound at the stump
- Fever, chills, or systemic symptoms
- Acute change in stump shape or fit suggesting bone or vascular issue
- Bleeding from a bite site lasting more than 24 hours
- Sudden severe worsening of phantom pain unresponsive to usual medications
- Hives, facial or throat swelling, or breathing difficulty
What this does NOT mean
- This is not FDA-cleared for phantom limb pain.
- No controlled trial or case report of leech therapy for phantom limb pain was identified; mirror therapy and graded motor imagery are central nervous system interventions, not peripheral.
- It does not replace pharmacotherapy with RCT support (gabapentinoids, TCAs, duloxetine).
- Trauma to an amputation stump may trigger neuroma pain or worsen phantom sensation.
- Diabetic and vascular amputees have particularly high infection risk - the population most likely to seek this therapy is often the population for whom it is most dangerous.
Safety cross-references
Clinical Profile
- Category
- Neurological
- ICD-10
- G54.6, G54.7
- Safety tier
- High
Evidence Summary
Phantom limb pain follows a large proportion of amputations and is best understood through cortical reorganization and peripheral neuroma contributions. Evidence-based management includes mirror therapy, graded motor imagery, virtual reality rehabilitation, gabapentinoids, and targeted muscle reinnervation surgery. No controlled trial or case report of leech therapy for phantom limb pain was identified in PubMed, Europe PMC or ClinicalTrials.gov; use is investigational only. The nearest report is an uncontrolled Russian series of 27 patients with post-traumatic limb stumps (Sulim 1997, conference proceedings, as summarized in Baskova and Isakhanyan 2004), in which leeches were applied and the pain syndrome was reported as eliminated in all cases; it did not study phantom pain separately. The predominantly cortical mechanisms of phantom pain are not addressed by leech pharmacology, and no controlled evidence shows that leech application affects phantom or stump-pain components.
What the books describe
Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.
- Phantom pain under that name is not mentioned in either of the two books; the closest to the topic is hirudotherapy of limb stumps, which Baskova and Isakhanyan write about[B1][B3].
- Baskova and Isakhanyan include postamputation stumps of the upper and lower limbs in the list of indications for hirudotherapy[B1].
- They retell the observation of Sulim (1997) in 27 injured patients with posttraumatic stumps of the arms and legs: hirudotherapy was prescribed in the recovery period, and, according to the retelling, in all cases the pain disappeared, a measure of blood circulation (the rheographic index) approached normal, and the rheological blood parameters (the properties of its flow) normalized[B1].
- It is not clear from the retelling which pain exactly is meant — phantom pain, pain in the stump itself or another kind — whether there was a comparison group and how long the patients were followed[B1].
- Both books name hemophilia and the use of anticoagulants as contraindications (Baskova and Isakhanyan; Flecken and Michalsen in the chapter on contraindications)[B1][B3].
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)
Contraindications
- Hemophilia or another bleeding disorder
- Taking anticoagulants (blood thinners such as warfarin or heparin)
- Anemia or suppressed blood formation
- Low blood pressure, shock, collapse or fainting
- Severe wasting (cachexia)
- Intolerance of leeches or a history of severe allergic reactions
- Pregnancy
- Stomach or duodenal ulcer, erosive gastritis
- Acute infectious disease or high fever
- Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
- Drinking alcohol at the time of treatment
- No consent from the patient
- Active deep vein thrombosis (acute phase)
- Critical limb ischemia (ABI <0.4)
- Acute postoperative residual limb (<8 weeks from amputation)
- Active stump infection or wound dehiscence
- Severe peripheral vascular disease in residual limb
Related Conditions
Complex Regional Pain Syndrome (Type I, Investigational)
Highly investigational adjunct for CRPS Type I; one case report and no controlled study identified; multidisciplinary pain management and physiotherapy remain primary.
Post-Stroke Hemiplegia (Investigational Adjunct)
Investigational adjunct to physical/occupational therapy in chronic post-stroke hemiplegia; no RCT support; not for acute stroke care.
Spasticity Post-Spinal Cord Injury (Investigational Adjunct)
Investigational adjunct for muscular spasticity after SCI; no clinical study identified; baclofen (oral or intrathecal) and physiotherapy remain primary.
Cervical Radiculopathy
Investigational use for cervical radiculopathy; no verifiable published trial specific to this indication.
References
- [B1]
Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]
Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.
- [B3]
Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy
ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.
The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.